Showing results (231-240 of 824) with videos related to
Sort By:
Pageof 83
Reviews in Clinical and Experimental Hematology|March 6, 2003
Novel biologically based therapeutic strategies in myelomaDeepak Gupta, Teru Hideshima, Kenneth C AndersonExpert Review of Anticancer Therapy|October 6, 2006
Therapeutic use of immunomodulatory drugs in the treatment of multiple myelomaNoopur Raje, Teru Hideshima, Kenneth C AndersonExperimental Hematology|June 30, 2015
Novel therapeutic strategies for multiple myelomaNaoya Mimura, Teru Hideshima, Kenneth C AndersonImmunological Reviews|July 9, 2003
Novel therapeutic approaches for multiple myelomaTeru Hideshima, Paul Richardson, Kenneth C AndersonMolecular & Cellular Oncology|June 17, 2016
Awakening the Hippo co-activator YAP1, a mercurial cancer gene, in hematologic cancersFrancesca Cottini, Kenneth C Anderson, Giovanni TononPlos One|December 3, 2015
Combination of a Selective HSP90α/β Inhibitor and a RAS-RAF-MEK-ERK Signaling Pathway Inhibitor Triggers Synergistic Cytotoxicity in Multiple Myeloma CellsRikio Suzuki, Shohei Kikuchi, Takeshi Harada, et al.British Journal of Haematology|March 25, 2010
Blockade of the MEK/ERK signalling cascade by AS703026, a novel selective MEK1/2 inhibitor, induces pleiotropic anti-myeloma activity in vitro and in vivoKihyun Kim, Sun-Young Kong, Mariateresa Fulciniti, et al.Blood Reviews|December 4, 2010
Multiple myeloma: biology of the diseaseAnuj Mahindra, Teru Hideshima, Kenneth C AndersonInternational Journal of Hematology|April 22, 2016
Histone deacetylase inhibitors in multiple myeloma: from bench to bedsideTakeshi Harada, Teru Hideshima, Kenneth C AndersonBlood Cancer Journal|September 8, 2018
The biological significance of histone modifiers in multiple myeloma: clinical applicationsHiroto Ohguchi, Teru Hideshima, Kenneth C AndersonPageof 83